MGTA Annual Total Long Term Liabilities
$26.14 M
+$19.74 M+308.47%
31 December 2022
Summary:
As of January 20, 2025, MGTA annual total long term liabilities is $26.14 million, with the most recent change of +$19.74 million (+308.47%) on December 31, 2022. During the last 3 years, it has risen by +$19.93 million (+321.17%).MGTA Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MGTA Quarterly Long Term Liabilities
$0.00
$0.000.00%
30 June 2023
Summary:
As of January 20, 2025, MGTA quarterly total long term liabilities is $0.00, unchanged on June 30, 2023. Over the past year, it has dropped by -$28.19 million (-100.00%).MGTA Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MGTA Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +308.5% | -100.0% |
| 3 y3 years | +321.2% | -100.0% |
| 5 y5 years | +100.0% | -100.0% |
MGTA Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | at high | -100.0% |
Magenta Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $0.00(0.0%) |
| Mar 2023 | - | $0.00(-100.0%) |
| Dec 2022 | $26.14 M(+308.5%) | $26.14 M(-3.8%) |
| Sept 2022 | - | $27.18 M(-3.6%) |
| June 2022 | - | $28.19 M(-3.2%) |
| Mar 2022 | - | $29.10 M(+354.8%) |
| Dec 2021 | $6.40 M(+1.8%) | $6.40 M(-0.0%) |
| Sept 2021 | - | $6.40 M(-0.0%) |
| June 2021 | - | $6.40 M(+0.8%) |
| Mar 2021 | - | $6.36 M(+1.1%) |
| Dec 2020 | $6.28 M | $6.28 M(+1.2%) |
| Sept 2020 | - | $6.21 M(-3.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2020 | - | $6.44 M(+1.7%) |
| Mar 2020 | - | $6.34 M(+2.1%) |
| Dec 2019 | $6.21 M(+398.1%) | $6.21 M(+2.2%) |
| Sept 2019 | - | $6.08 M(+2.2%) |
| June 2019 | - | $5.95 M(+3.1%) |
| Mar 2019 | - | $5.77 M(+363.0%) |
| Dec 2018 | $1.25 M(>+9900.0%) | $1.25 M(+15.4%) |
| Sept 2018 | - | $1.08 M(+35.7%) |
| June 2018 | - | $796.00 K(>+9900.0%) |
| Mar 2018 | - | $0.00(0.0%) |
| Dec 2017 | $0.00(0.0%) | $0.00 |
| Dec 2016 | $0.00 | - |
FAQ
- What is Magenta Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Magenta Therapeutics?
- What is Magenta Therapeutics annual total long term liabilities year-on-year change?
- What is Magenta Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Magenta Therapeutics?
- What is Magenta Therapeutics quarterly long term liabilities year-on-year change?
What is Magenta Therapeutics annual total long term liabilities?
The current annual total long term liabilities of MGTA is $26.14 M
What is the all time high annual total long term liabilities for Magenta Therapeutics?
Magenta Therapeutics all-time high annual total long term liabilities is $26.14 M
What is Magenta Therapeutics annual total long term liabilities year-on-year change?
Over the past year, MGTA annual total long term liabilities has changed by +$19.74 M (+308.47%)
What is Magenta Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of MGTA is $0.00
What is the all time high quarterly long term liabilities for Magenta Therapeutics?
Magenta Therapeutics all-time high quarterly total long term liabilities is $29.10 M
What is Magenta Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, MGTA quarterly total long term liabilities has changed by -$28.19 M (-100.00%)